Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Conti

Showing results (11-20 of 345) with videos related to

Pageof 35
Sort By:
Autoimmunity Reviews|July 30, 2010
Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coinFabrizio Conti, Carlo Perricone, Fulvia Ceccarelli, et al.
Rheumatology (Oxford, England)|August 26, 2020
Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: a case reportFulvia Ceccarelli, Silvia Mancuso, Ramona Lucchetti, et al.
Annals of the New York Academy of Sciences|July 21, 2006
Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosusGuido Valesini, Cristiano Alessandri, Domenico Celestino, et al.
Clinical Reviews in Allergy & Immunology|July 3, 2010
Toll-like receptors and lupus nephritisFabrizio Conti, Francesca Romana Spinelli, Cristiano Alessandri, et al.
Autoimmunity Reviews|November 1, 2011
Does seronegative antiphospholipid syndrome really exist?Ricard Cervera, Fabrizio Conti, Andrea Doria, et al.
Annals of the Rheumatic Diseases|April 4, 2020
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemicFrancesca Romana Spinelli, Fulvia Ceccarelli, Manuela Di Franco, et al.
Journal of Inflammation Research|June 8, 2022
Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical EvidenceFlorenzo Iannone, Fabrizio Conti, Alberto Cauli, et al.
Lupus|July 1, 2021
SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a caseFulvia Ceccarelli, Giulio Olivieri, Francesco Natalucci, et al.
Core Evidence|March 21, 2014
Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritisManuela Di Franco, Maria Chiara Gerardi, Bruno Lucchino, et al.
Annals of the Rheumatic Diseases|April 30, 2020
Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev <i>et al</i>Francesca Romana Spinelli, Fulvia Ceccarelli, Manuela Di Franco, et al.
Pageof 35

Showing results (11-20 of 345) with videos related to

Sort By:
Pageof 35
Autoimmunity Reviews|July 30, 2010
Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coinFabrizio Conti, Carlo Perricone, Fulvia Ceccarelli, et al.
Rheumatology (Oxford, England)|August 26, 2020
Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: a case reportFulvia Ceccarelli, Silvia Mancuso, Ramona Lucchetti, et al.
Annals of the New York Academy of Sciences|July 21, 2006
Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosusGuido Valesini, Cristiano Alessandri, Domenico Celestino, et al.
Clinical Reviews in Allergy & Immunology|July 3, 2010
Toll-like receptors and lupus nephritisFabrizio Conti, Francesca Romana Spinelli, Cristiano Alessandri, et al.
Autoimmunity Reviews|November 1, 2011
Does seronegative antiphospholipid syndrome really exist?Ricard Cervera, Fabrizio Conti, Andrea Doria, et al.
Annals of the Rheumatic Diseases|April 4, 2020
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemicFrancesca Romana Spinelli, Fulvia Ceccarelli, Manuela Di Franco, et al.
Journal of Inflammation Research|June 8, 2022
Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical EvidenceFlorenzo Iannone, Fabrizio Conti, Alberto Cauli, et al.
Lupus|July 1, 2021
SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a caseFulvia Ceccarelli, Giulio Olivieri, Francesco Natalucci, et al.
Core Evidence|March 21, 2014
Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritisManuela Di Franco, Maria Chiara Gerardi, Bruno Lucchino, et al.
Annals of the Rheumatic Diseases|April 30, 2020
Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev <i>et al</i>Francesca Romana Spinelli, Fulvia Ceccarelli, Manuela Di Franco, et al.
Pageof 35